Cargando…
N-(1,3,4-Oxadiazol-2-yl)Benzamides as Antibacterial Agents against Neisseria gonorrhoeae
The Centers for Disease Control and Prevention (CDC) recognizes Neisseria gonorrhoeae as an urgent-threat Gram-negative bacterial pathogen. Additionally, resistance to frontline treatment (dual therapy with azithromycin and ceftriaxone) has led to the emergence of multidrug-resistant N. gonorrhoeae,...
Autores principales: | Naclerio, George A., Abutaleb, Nader S., Alhashimi, Marwa, Seleem, Mohamed N., Sintim, Herman O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957578/ https://www.ncbi.nlm.nih.gov/pubmed/33671065 http://dx.doi.org/10.3390/ijms22052427 |
Ejemplares similares
-
Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection
por: Elhassanny, Ahmed E. M., et al.
Publicado: (2022) -
Dithiocarbamates effectively inhibit the α-carbonic anhydrase from Neisseria gonorrhoeae
por: Giovannuzzi, Simone, et al.
Publicado: (2021) -
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
por: Abutaleb, Nader S., et al.
Publicado: (2021) -
Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae
por: Elkashif, Ahmed, et al.
Publicado: (2020) -
Substituted salicylic acid analogs offer improved potency against multidrug-resistant Neisseria gonorrhoeae and good selectivity against commensal vaginal bacteria
por: Almolhim, Hanan, et al.
Publicado: (2023)